Pharmaceuticals Global

Global ALS Treatment Market Analysis, 2024–2034

Global ALS Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug, Route, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Global · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $856.0 Mn Estimated value
Estimate 2025 $915.9 Mn Estimated value
Projected 2034 $1.68 Bn 83.8% Adds $768.0 Mn over 9 forecast years
CAGR 2025–2034 7.0% Faster than 32% of 179 Pharmaceuticals markets here
Key players 5
  • Worldwide, the largest is US at $378.7 Mn.
  • Fastest growing: India at 9.6% a year.

Market size projection

Global

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$768.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
ALS Treatment Market market size by year, Global
YearMarket sizeChange that yearSince 2025
2024 (estimate) $856.0 Mn — —
2025 (base) $915.9 Mn +$59.9 Mn —
2026 (forecast) $980.0 Mn +$64.1 Mn +7%
2027 (forecast) $1.05 Bn +$68.6 Mn +14.5%
2028 (forecast) $1.12 Bn +$73.4 Mn +22.5%
2029 (forecast) $1.20 Bn +$78.5 Mn +31.1%
2030 (forecast) $1.28 Bn +$84.0 Mn +40.3%
2031 (forecast) $1.37 Bn +$89.9 Mn +50.1%
2032 (forecast) $1.47 Bn +$96.2 Mn +60.6%
2033 (forecast) $1.57 Bn +$103.0 Mn +71.8%
2034 (forecast) $1.68 Bn +$110.2 Mn +83.8%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global (this report) $915.9 Mn
  2. North America $409.4 Mn
  3. US $378.7 Mn
  4. APAC $203.2 Mn
  5. Europe $159.0 Mn
  6. China $82.1 Mn
  7. Canada $64.1 Mn
  8. Japan $52.6 Mn
  9. Latin America $44.9 Mn
  10. Germany $35.7 Mn
  11. Middle East $34.4 Mn
  12. France $24.5 Mn
  13. UK $22.0 Mn
  14. Brazil $22.1 Mn
  15. Ecuador $20.1 Mn
  16. Italy $18.9 Mn
  17. Saudi Arabia $17.3 Mn
  18. India $17.1 Mn
  19. Spain $15.5 Mn
  20. Mexico $15.6 Mn
  21. Africa $13.2 Mn
  22. Australia $11.2 Mn
  23. Russia $10.1 Mn
  24. New Zealand $9.9 Mn
  25. South Africa $5.9 Mn
  26. UAE $4.5 Mn
  27. Egypt $2.3 Mn
  28. Philippines $1.9 Mn
  29. Hong Kong $1.4 Mn
  30. Malaysia $1.4 Mn
  31. Singapore $1.2 Mn
  32. Thailand $1.0 Mn
  33. Kenya $0.6 Mn

The Global ALS Treatment Market Analysis Executive Summary

ALS treatments aim to slow amyotrophic lateral sclerosis, a disease that destroys nerve cells controlling muscles.

Key segments of the ALS Treatment market include drug (Riluzole, Edaravone and Tofersen) and route (Oral, Intravenous and Intrathecal).

Global ALS Treatment Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the ALS Treatment market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the ALS Treatment market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the ALS Treatment market.

Competitive Landscape for ALS Treatment Market in Global

The ALS Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for ALS Treatment Market in Global

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for ALS Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Global.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in ALS Treatment right now, from free public sources.

Clinical trials

279 active trials worldwide

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Neuralink 6 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Eli Lilly and Company 4 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Biogen Inc 4 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Cognixion 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. AB Science 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 138 papers since 2021 (worldwide)

  1. Edaravone for Potential Mitigation of Oxidative Stress and Inflammation in Kidney Disease. Biomolecules, 2026
  2. Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products. Expert opinion on investigational drugs, 2026
  3. Therapeutic Challenges and Future Breakthroughs in Amyotrophic Lateral Sclerosis: From Precision Medicine to Innovative Trial Design. Drug design, development and therapy, 2026
  4. ALSUntangled #84 - ivermectin. Amyotrophic lateral sclerosis & frontotemporal degeneration, 2026
  5. Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

ALS Treatment in context

Questions, answered with public data

How many clinical trials on ALS Treatment are running worldwide?
279 studies are recruiting, active or about to start worldwide.[1]
How much research is published on ALS Treatment?
PubMed lists 138 papers added since January 2021 that match this market, worldwide.[2]

[1] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

[2] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about ALS Treatment in Global? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Alzheimer's Diagnosis: Blood Tests and Earlier Answers57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help… Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Global

See all
Same topic, other categories

Related on rare diseases and brain and nerves

See the topic